Ra Capital Management, L.P. Icosavax, Inc. Transaction History

Ra Capital Management, L.P.

  • $6.64 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$5.95 - $15.79 $35.5 Million - $94.2 Million
5,963,565 New
5,963,565 $94 Million
Q1 2022

May 16, 2022
BUY
$4.41 - $22.5 $812,401 - $4.14 Million
184,218 Added 3.19%
5,963,565 $42 Million
Q3 2021

Nov 15, 2021
BUY
$24.85 - $40.25 $144 Million - $233 Million
5,779,347 New
5,779,347 $171 Million

Others Institutions Holding ICVX

# of Institutions
2
Shares Held
1.37M
Call Options Held
0
Put Options Held
0
View Full List

About Icosavax, Inc.

ICVX Quotes by TradingView
  • Ticker ICVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,885,200
  • Description
  • Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical tri...
More about ICVX
Track This Portfolio

Track Ra Capital Management, L.P. Portfolio

Follow Ra Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Ra Capital Management, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email